The original COVID-19 vaccines made by Pfizer and Moderna no longer are authorized in the U.S., the Food and Drug Administration announced on Tuesday, April 18.
Now, both companies’ newer COVID-19 vaccines, which include a component of the original vaccine and a second component targeting the omicron variant, are authorized as the main dose for people 6 months and older, the FDA said in a news release.
Anyone unvaccinated against the virus looking to get either company’s shot would get a single “bivalent” dose instead of two shots of the original “monovalent” vaccines, according to the agency. For most people who’ve received one dose of the newer shots, they aren’t eligible for an extra shot, the FDA said.
Certain individuals, however, such as those 65 and older, are eligible for an extra dose. The majority of people vaccinated with an original COVID-19 vaccine dose can get a single shot targeting omicron, according to the agency.
Read More
Star-Telegram Rating
Discover more from News Facts Network
Subscribe to get the latest posts sent to your email.
